Abstract 2615: Heterogeneity of HER2 expression in gastric cancer (GC) leads to high deviation rates between local and central testing and hampers efficacy of anti-HER2 therapy: Survival results from the VARIANZ study
暂无分享,去创建一个
J. Hasenauer | F. Lordick | B. Rau | T. Decker | D. Maier | E. Raimúndez | B. Luber | C. Wittekind | I. Haffner | K. Schierle | A. Kretzschmar | M. Ahlborn | G. Siegler | S. Fuxius | L. F. V. Weikersthal | J. R. Knorrenschild